本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Rhythm Pharmaceuticals Inc.

65.77
-1.1500-1.72%
盘后65.770.00000.00%16:20 EDT
成交量:62.82万
成交额:4,149.00万
市值:41.84亿
市盈率:-23.33
高:67.44
开:67.05
低:65.61
收:66.92
数据加载中...
2024/02/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/04

重要事件披露

Form 8-K - Current report
2024/01/04

重要事件披露

Form 8-K - Current report
2023/12/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/19

重要事件披露

Form 8-K - Current report
2023/12/06

重要事件披露

Form 8-K - Current report
2023/12/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities